Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification

B Li, J Jiang, YG Assaraf, H Xiao, ZS Chen… - Drug resistance …, 2020 - Elsevier
Despite the development of targeted therapy, drug resistance remains a primary hindrance
to curative treatment of various cancers. Among several novel approaches to overcome drug …
被引用次数：127 相关文章

Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification

B Li, J Jiang, YG Assaraf, H Xiao… - Drug resistance …, 2020 - pubmed.ncbi.nlm.nih.gov
Despite the development of targeted therapy, drug resistance remains a primary hindrance
to curative treatment of various cancers. Among several novel approaches to overcome drug …

Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification.

B Li, J Jiang, YG Assaraf, H Xiao, ZS Chen… - … Updates: Reviews and …, 2020 - europepmc.org
Despite the development of targeted therapy, drug resistance remains a primary hindrance
to curative treatment of various cancers. Among several novel approaches to overcome drug …